Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine

Endocrinology

Volumn 141, Issue 11, 2000, Pages 4194-4201

  Lovshin, J ^a   Yusta, B ^a   Iliopoulos, I ^a   Migirdicyan, A ^a   Dableh, L ^a   Brubaker, P L ^a   Drucker, D J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 2 DERIVATIVE; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; GLYCINE DERIVATIVE; GLYCINE2 GLUCAGON LIKE PEPTIDE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; FETUS; GASTROINTESTINAL MUCOSA; IMMUNOREACTIVITY; INTESTINE ABSORPTION; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TISSUE SPECIFICITY;

EID: 0033695821     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.11.7773     Document Type: Article

References (46)

1. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
2. Role of prohormone converrases in the tissue-specific processing of proglucagon
3. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro
4. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut
5. Glucagon-like peptide 2
6. Induction of intestinal epithelial proliferation by glucagon-like peptide 2
7. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice
8. The hormonal pattern of intestinal adaptation [a major role for enteroglucagon]
9. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
10. Prevention of parenteral nutrition-induced gut hyoplasia by coinfusion of glucagon-like peptide-2
11. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion
12. GLP-2 augments the adaptive response to massive intestinal resection in rat
13. Ontogeny of glucagon messenger RNA and encoded precursor in the rat intestine
14. Developmental and tissue-specific regulation of proglucagon gene expression
15. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
16. Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures
17. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
18. Protein measurement with the folin phenol reagent
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine
21. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues
22. Intestinal response to growth factors administered alone or in combination with h[Gly2]-Glucagon-like peptide 2
23. Biological determinants of intestinotrophic properties of GLP-2 in vivo
24. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas
25. Regulation of the biological activity of glucagon-like peptide 2 by dipeptidyl peptidase IV
26. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide 2
27. Fetal rat intestinal cells in monolayer culture: A new in vitro system to study the glucagon-like immunoreactive peptides
28. Expression cloning and signaling properties of the rat glucagon receptor
29. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1
30. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse
31. Hyperglycaemia induced by glucose infusion in the unrestrained pregnant rat during the last three days of gestation: Metabolic and hormonal changes in the mother and the fetuses
32. Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: How much is enough?
33. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide receptor gene
34. Development of glucagon sensitivity in neonatal rat liver
35. Ontogeny of endocrine cells in porcine gut and pancreas
36. Peptide YY expression is an early event in colonic endocrine cell differentiation: Evidence from normal and transgenic mice
37. Immunocytochemical studies suggest two pathways for enteroendocrine cell differentiation in the colon
38. Ontogeny of glucagon-like immunoreactive peptides in rat intestine
39. Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro
40. Evidence for redundancy in propeptide/prohormone convertase activities in processing proglucagon: An antisense study
41. Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide
42. Developmental expression of proprotein convertase 1/3 in the rat
43. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription
44. Development of the human gastrointestinal tract: Twenty years of progress
45. Changing trends in necrotizing enterocolitis. Experience with 302 cases in two decades
46. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced marine enteritis